Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion type Assertion NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_head.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion description "[XIAP and survivin are potential therapeutic targets for pancreatic cancer, and elucidating their association with cell proliferation and apoptosis may lead to the development of novel treatments for this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_provenance.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion evidence source_evidence_literature NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_provenance.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion SIO_000772 21479361 NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_provenance.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion wasDerivedFrom befree-20140225 NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_provenance.
- NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_assertion wasGeneratedBy ECO_0000203 NP385727.RA1IREBmY5DXLnWJMG8auaCVZSz1VK1ff3cCmxiQDtgSM130_provenance.